David Scheie

2.8k total citations
47 papers, 1.1k citations indexed

About

David Scheie is a scholar working on Epidemiology, Neurology and Surgery. According to data from OpenAlex, David Scheie has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 21 papers in Neurology and 14 papers in Surgery. Recurrent topics in David Scheie's work include Meningioma and schwannoma management (23 papers), Neurofibromatosis and Schwannoma Cases (14 papers) and Pituitary Gland Disorders and Treatments (8 papers). David Scheie is often cited by papers focused on Meningioma and schwannoma management (23 papers), Neurofibromatosis and Schwannoma Cases (14 papers) and Pituitary Gland Disorders and Treatments (8 papers). David Scheie collaborates with scholars based in Denmark, Norway and Sweden. David Scheie's co-authors include Eirik Helseth, Torstein R. Meling, Michele Da Broi, Pål Rønning, Søren Just Christensen, Annette Johansen, Daniel Kondziella, Joan Højgaard, Iver A. Langmoen and Morten Lund‐Johansen and has published in prestigious journals such as Neurology, Cancer and Scientific Reports.

In The Last Decade

David Scheie

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Scheie Denmark 17 632 617 386 270 197 47 1.1k
A. Nicolato Italy 24 766 1.2× 825 1.3× 394 1.0× 430 1.6× 137 0.7× 69 1.5k
Ralf Buhl Germany 22 608 1.0× 399 0.6× 281 0.7× 271 1.0× 95 0.5× 49 1.1k
Douglas A. Hardesty United States 16 323 0.5× 514 0.8× 455 1.2× 246 0.9× 297 1.5× 82 1.1k
Stéphane Goutagny France 14 664 1.1× 628 1.0× 158 0.4× 187 0.7× 93 0.5× 34 930
Prashant Chittiboina United States 23 361 0.6× 286 0.5× 613 1.6× 305 1.1× 545 2.8× 103 1.6k
Melita Steiner United States 18 816 1.3× 673 1.1× 146 0.4× 362 1.3× 132 0.7× 22 1.4k
Kita Sallabanda Spain 11 789 1.2× 1.1k 1.8× 411 1.1× 381 1.4× 239 1.2× 22 1.3k
Jana Ivanidze United States 18 419 0.7× 338 0.5× 95 0.2× 211 0.8× 81 0.4× 80 1.1k
Masaaki Usui Japan 17 774 1.2× 269 0.4× 289 0.7× 179 0.7× 204 1.0× 33 1.2k
Leif‐Erik Bohman United States 18 276 0.4× 315 0.5× 409 1.1× 159 0.6× 201 1.0× 23 985

Countries citing papers authored by David Scheie

Since Specialization
Citations

This map shows the geographic impact of David Scheie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Scheie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Scheie more than expected).

Fields of papers citing papers by David Scheie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Scheie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Scheie. The network helps show where David Scheie may publish in the future.

Co-authorship network of co-authors of David Scheie

This figure shows the co-authorship network connecting the top 25 collaborators of David Scheie. A scholar is included among the top collaborators of David Scheie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Scheie. David Scheie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torp, Sverre H., et al.. (2023). Clinicopathological significance of concurrent ErbB receptor expression in human meningioma. Molecular and Clinical Oncology. 19(4). 79–79.
2.
Maier, Andrea Daniela, et al.. (2023). DNA methylation profile of human dura and leptomeninges. Journal of Neuropathology & Experimental Neurology. 82(7). 641–649.
3.
Maier, Andrea Daniela, Christian Mirian, Jeppe Haslund-Vinding, et al.. (2022). Loss of H3K27me3 in WHO grade 3 meningioma. Brain Tumor Pathology. 39(4). 200–209. 6 indexed citations
4.
Maier, Andrea Daniela, Jørgen Vinsløv Hansen, Helle Broholm, et al.. (2021). Pathologic Characteristics of Pregnancy-Related Meningiomas. Cancers. 13(15). 3879–3879. 9 indexed citations
5.
Bruland, Ove, Hrvoje Miletić, Lars Poulsgaard, et al.. (2021). Genetic alterations associated with malignant transformation of sporadic vestibular schwannoma. Acta Neurochirurgica. 164(2). 343–352. 4 indexed citations
6.
Skjøth‐Rasmussen, Jane, et al.. (2021). A new uPAR-targeting fluorescent probe for optical guided intracranial surgery in resection of a meningioma—a case report. Acta Neurochirurgica. 164(1). 267–271. 5 indexed citations
7.
Haslund-Vinding, Jeppe, Jane Skjøth‐Rasmussen, Lars Poulsgaard, et al.. (2021). Proposal of a new grading system for meningioma resection: the Copenhagen Protocol. Acta Neurochirurgica. 164(1). 229–238. 11 indexed citations
8.
Johansen, Annette, Søren Just Christensen, David Scheie, Joan Højgaard, & Daniel Kondziella. (2019). Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies. Neurology. 92(14). 663–674. 116 indexed citations
9.
Lemée, Jean‐Michel, Holger Joswig, Michele Da Broi, et al.. (2019). WHO grade I meningiomas: classification-tree for prognostic factors of survival. Neurosurgical Review. 43(2). 749–758. 11 indexed citations
10.
Faber, Carsten, et al.. (2019). Isolated Ocular Sarcoidosis Mimicking Ring Melanoma. Ocular Oncology and Pathology. 6(3). 180–183. 1 indexed citations
11.
Meling, Torstein R., Michele Da Broi, David Scheie, Eirik Helseth, & Nicolas R. Smoll. (2019). Meningioma Surgery–Are We Making Progress?. World Neurosurgery. 125. e205–e213. 38 indexed citations
12.
13.
Meling, Torstein R., Michele Da Broi, David Scheie, & Eirik Helseth. (2018). Skull base versus non-skull base meningioma surgery in the elderly. Neurosurgical Review. 42(4). 961–972. 27 indexed citations
14.
Meling, Torstein R., Michele Da Broi, David Scheie, & Eirik Helseth. (2018). Meningiomas: skull base versus non-skull base. Neurosurgical Review. 42(1). 163–173. 77 indexed citations
15.
Østrup, Oľga, Karsten Nysom, David Scheie, et al.. (2018). Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent Cancer. Frontiers in Pediatrics. 6. 114–114. 17 indexed citations
16.
Grønborg, Sabine, Lotte Risom, Jakob Ek, et al.. (2018). A Faroese founder variant in TBCD causes early onset, progressive encephalopathy with a homogenous clinical course. European Journal of Human Genetics. 26(10). 1512–1520. 12 indexed citations
17.
Rossing, Maria, Christina W. Yde, Astrid Sehested, et al.. (2017). Genomic diagnostics leading to the identification of a TFG-ROS1 fusion in a child with possible atypical meningioma. Cancer Genetics. 212-213. 32–37. 11 indexed citations
18.
Fiskerstrand, Torunn, Gunnar Houge, David Scheie, et al.. (2009). Identification of a Gene for Renal-Hepatic-Pancreatic Dysplasia by Microarray-Based Homozygosity Mapping. Journal of Molecular Diagnostics. 12(1). 125–131. 15 indexed citations
19.
Klæboe, Lars, Stefan Lönn, David Scheie, et al.. (2005). Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968–1997. International Journal of Cancer. 117(6). 996–1001. 90 indexed citations
20.
Lund‐Johansen, Morten, David Scheie, Tomm B. Müller, Tryggve Lundar, & Eirik Helseth. (2001). Neurosurgical treatment of meningiomas in children and young adults. Child s Nervous System. 17(12). 719–723. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026